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Abstract 
Non-typhoidal salmonellosis remains a pressing public health problem worldwide. Quinolones, particularly fluoroqui-
nolones, are widely used to treat various infections, including non-typhoidal salmonellosis, which can be a serious illness. 
The emergence of fluoroquinolone-resistant Salmonella has resulted in treatment failure and high mortality rates. In this 
study, we estimated the presence of plasmid-mediated quinolone resistance (PMQR) genes in Salmonella enterica isolated 
from human salmonellosis patients in South Korea from 2016 to 2019. We evaluated the association of these genes with 
fluoroquinolone susceptibility. Antimicrobial susceptibility tests for Salmonella isolates were performed using the Vitek II 
system, and the minimum inhibitory concentrations (MIC) of ciprofloxacin and levofloxacin were determined using the 
E-test method. Plasmid-mediated quinolone resistance (PMQR) genes were detected by PCR amplification and quinolone 
resistance-determining regions (QRDRs) of the gyrA and parC genes were analyzed following Sanger sequencing of the 
PCR products. Thirty-four Salmonella strains with reduced susceptibility to fluoroquinolones (ciprofloxacin MIC ≥ 0.125 
µg/mL and levofloxacin MIC ≥ 0.25 µg/mL) were selected from 208 human clinical Salmonella isolates. Among them, 22 
Salmonella strains harbored one PMQR gene (qnrA, qnrB, or qnrS), and three Salmonella strains carried two PMQR genes 
(qnrS and aac(6′)-Ib-cr or qnrA and qnrB). qnrS was the most common PMQR gene. Serotyping revealed that Salmonella 
4,[5]12:i:- (32.4%, 11/34) and Salmonella Typhimurium (29.4%, 10/34) were the two most predominant serovars, and Multi-
locus sequence typing (MLST) showed that ST19 and ST34 were the most frequent sequence types. In conclusion, qnr 
gene-positive Salmonella 4,[5],12:i:- and Salmonella Typhimurium were the main serovars responsible for reduced suscep-
tibility to fluoroquinolones. Therefore, our findings suggest that PMQR-positive Salmonella strains, which can be isolated 
from various samples including human, food, and the environment, should be carefully monitored.
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Background
Salmonellosis is a disease caused by Salmonella that 
usually produces acute onset of fever, abdominal pain, 
diarrhea, and vomiting. Antimicrobial therapy is not rec-
ommended in healthy individuals with mild or moder-
ate infection [1]. This is due to the use of antimicrobials 
may not shorten the duration of clinical symptoms, but 
is rather a risk for prolonged Salmonella infection [2]. 
However, high-risk groups including infants, the elderly, 
and immunocompromised patients may require anti-
microbial therapy [1]. Quinolones, particularly fluoro-
quinolones (e.g., ciprofloxacin and levofloxacin), are a 
critically important antimicrobial class, and invasive Sal-
monella infections in adults are commonly treated with 
quinolones. However, because quinolones are frequently 
used in human and veterinary medicine, resistance to 
this antimicrobial class has evolved among Salmonella 
strains [3]. Fluoroquinolone resistance is mostly associ-
ated with chromosomal mutations in the bacterial genes 
encoding targeted enzymes, DNA gyrase and topoi-
somerase IV (quinolone resistance determining region, 
QRDR). However, fluoroquinolone resistance can also be 
acquired by plasmid encoded genes (plasmid-mediated 
quinolone resistance, PMQR). There are several well-
known PMQR gene groups, including qnr families (qnrA, 
qnrB, qnrC, qnrD, qnrE, qnrS, and qnrVC), antibiotic 
efflux pump-coding genes (qepA and oqxAB), antibiotic 
modification enzyme gene (aac(6)Ib-cr), and a newly 
described phosphorylase gene (crpP) [4]. According to 
previous studies, the qnr, aac(6′)-Ib-cr, and qepA genes 
are commonly detected in South Korea; therefore, we 
chose these genes to investigate in this study [5, 6]. The 
Qnr is a pentapeptide repeat protein that protects DNA 
gyrase and topoisomerase IV by inhibiting quinolone 
[7, 8]. The aac(6′)-Ib-cr gene encodes aminoglycoside 
acetyltransferase that simultaneously induces resistance 
against aminoglycoside and fluoroquinolone [9]. PMQR 
facilitates the spread of quinolone resistance, leading 
to the emergence of high quinolone resistance, making 
infections difficult to treat [10]. Therefore, the presence 
of PMQR genes in Salmonella strains with reduced sus-
ceptibility to fluoroquinolones indicates that continuous 
monitoring and clinical attention are required. Although 
PMQR genes confer reduced susceptibility of bacteria 
to fluoroquinolones, their influence on nalidixic acid 
susceptibility is minor [11]. The United States National 
Antimicrobial Resistance Monitoring System (NARMS) 
has indicated the presence of PMQR genes among Sal-
monella and other enteric bacteria isolated from humans, 
retail meat, and food animals in the United States. Addi-
tionally, NARMS recently reported an increase in the 
proportion of ciprofloxacin-non-susceptible strains lack-
ing nalidixic acid resistance [12]. In Canada, a relatively 
high prevalence of PMQR genes has been reported in 
human isolates of non-typhoidal Salmonella with resist-
ance and reduced susceptibility to fluoroquinolones [13]. 
Likewise, PMQR gene-positive Salmonella 4,[5],12:i:- 
were recently isolated from pigs, chickens, humans, 
geese, and cats in China [14]. In this study, we aim to 
estimate the presence of the plasmid-mediated quinolone 
resistance genes and their association with fluoroqui-
nolone susceptibility in non-typhoidal Salmonella iso-
lates from human clinical samples in South Korea from 
2016 to 2019.
Methods
Thirty-four nontyphoidal Salmonella strains with inter-
mediate resistance to quinolone or fluoroquinolone were 
selected and evaluated from 208 human clinical Salmo-
nella strains. The strains were isolated from fecal samples 
of diarrhea patients in Gyeonggi-do, South Korea, by the 
Research Institute of Health & Environment from 2016 
to 2019 (see Additional file  1). The rectal swab samples 
were plated on Salmonella–Shigella (SS) agar (Oxoid, 
Basingstoke, UK) and incubated at 37 °C for 18 to 24 h. 
Isolates with typical Salmonella phenotypes were con-
firmed using the Vitek II system with a GN card (bioMer-
ieux Inc., Marcy l’Etoile, France). Salmonella serotyping 
was done according to the White–Kauffmann–Le Minor 
scheme using slide agglutination test (O antigen) and 
tube agglutination test (H antigen) with antisera. The 
isolates were serotyped using the somatic (O) (provided 
from Korea Disease Control and Prevention Agency, 
KDCA) and flagella (H) antisera (Difco, Detroit, MI, 
USA). The absence of hin gene in the monophasic vari-
ant of Salmonella Typhimurium was confirmed by PCR. 
Antimicrobial susceptibility tests were performed using 
the Vitek II system with the AST-N169 card (bioMer-
ieux Inc.) according to the manufacturer’s instructions. 
The minimum inhibitory concentrations (MIC) of cip-
rofloxacin and levofloxacin were determined using the 
E-test method (bioMerieux Inc.). Quinolone and fluo-
roquinolone MIC values were confirmed according to 
CLSI guidelines [15]. In Salmonella, a ciprofloxacin 
MIC of 0.12–0.5 µg/mL is defined as intermediate and 
MIC ≥ 1 µg/mL is defined as resistant, while a levoflox-
acin MIC of 0.25–1 µg/mL is defined as intermediate 
and MIC ≥ 2 µg/mL is defined as resistant. Additionally, 
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a nalidixic acid MIC ≥ 32 µg/mL is defined as resistant, 
and there is no intermediate category. Total DNA was 
extracted from overnight cultures of Salmonella isolates 
using the Nextractor NX-48 system and NX-48 bacterial 
DNA kits (Genolution Inc., Seoul, Korea). PMQR genes 
(qnrA, qnrB, qnrS, aac(6′)-Ib-cr, and qepA) were detected 
by PCR amplification using primers described in previ-
ous studies [16–18]. The QRDR region of the gyrA and 
parC genes was each PCR-amplified using previously 
described primers [19]. PCR products were purified and 
Sanger sequenced by Macrogen Inc, Korea. The nucleo-
tide sequences of QRDRs in gyrA and parC genes were 
compared with the counterpart sequences of quinolone-
susceptible reference strain Salmonella Typhimurium 
LT2 (GenBank Accession number AE006468) using 
BLAST. Seven housekeeping genes (aroC, dnaN, hemD, 
hisD, purE, sucA, and thrA) were amplified using previ-
ously reported MLST primers (see Additional file 2). PCR 
products were sequenced by Macrogen (South Korea). 
Each isolate’s sequence type (ST) was assigned according 
to the PubMLST website. Phylogenetic analyses of the 
isolates using MLST-based clusters were conducted with 
BioNumerics software (Applied Maths, Sint-Martens-
Latem, Belgium). The correlation between PMQR genes 
and MIC values was analyzed by Fisher’s exact test using 
GraphPad Prism software v.5 (GraphPad Software Inc., 
La Jolla, CA). A P-value < 0.05 was considered to indicate 
statistical significance.
Results and discussion
Thirty-four Salmonella strains with reduced suscepti-
bility to fluoroquinolones were identified from Gyeo-
nggi-do, South Korea, from 2016 to 2019. Salmonella 
4,[5],12:i:- (32.4%, 11/34) and Salmonella Typhimurium 
(29.4%, 10/34) were the predominant serovars. Iso-
lated Salmonella serovars showing intermediate resist-
ance to quinolones, particularly fluoroquinolones, were 
presented in Table  1. In the last two decades, Salmo-
nella 4,[5],12:i:- has rapidly emerged worldwide [14]. In 
South Korea, the first foodborne outbreak of Salmonella 
4,[5],12:i:- was reported in 2008 [20]; the same serovar, 
which exhibits nalidixic acid resistance, was isolated from 
pigs and chickens in South Korea [21]. Similarly, most 
Salmonella 4,[5],12:i:- isolates from chickens, geese, and 
cats in China were resistant to nalidixic acid (52.5%) [14]. 
Isolates of enrofloxacin-resistant Salmonella 4,[5],12:i:- 
from swine in the United States have also been reported 
[22].
All 34 isolates (100%) showed reduced susceptibil-
ity to levofloxacin, 32 isolates (94.1%) showed reduced 
susceptibility to ciprofloxacin, and 27 isolates (79.4%) 
were also resistant to nalidixic acid. We obtained seven 
non-typhoidal Salmonella isolates that showed reduced 
susceptibility to fluoroquinolones and susceptibility 
to nalidixic acid. Resistance to nalidixic acid could be 
related to reduced susceptibility to fluoroquinolones 
because it typically required chromosomal mutations in 
the quinolone resistance-determining region (QRDR) or 
acquisitions of PMQR genes (Table 1). Reduced suscep-
tibility to fluoroquinolones without nalidixic acid resist-
ance indicated PMQR presence [10], and the US NARMS 
has found higher percentages of isolates with reduced 
susceptibility to ciprofloxacin than nalidixic acid resist-
ance since 2005 [12].
PMQR genes were detected in 25 (73.5%) out of 34 
Salmonella isolates, including one (2.9%) isolate posi-
tive for qnrA, two (5.9%) isolates positive for qnrB, 23 
(67.6 %) positive for qnrS, and two (5.9 %) positive for 
acc(6′)-Ib-cr (Table  1). The correlation between PMQR 
genes and MIC values was statistically insignificant. 
According to previous studies, the qnr gene family was 
predominantly detected in Salmonella strains isolated 
from travelers. Most of the strains carrying the qnrS 
gene showed reduced susceptibility to ciprofloxacin 
[21]. The qnrS gene was mostly harbored by Salmonella 
4,[5],12:i:- and Salmonella Typhimurium [23, 24]. The 
qepA gene was not detected in any isolate. According to 
a study on PMQR gene prevalence in clinical Enterobac-
teriaceae isolates from South Korea, qnrB was the most 
frequently observed PMQR gene before 2000, whereas 
qnrS, aac(6′)-Ib-cr, and qepA emerged after 2000 [25]. 
Although most PMQR-positive isolates possessed only 
one gene, two Salmonella Saintpaul isolates were positive 
for qnrS and acc(6′)-Ib-cr and one Salmonella Carno iso-
late was positive for qnrA and qnrB. Among the PMQR 
gene-positive Salmonella isolates from patients and tur-
key meat, Salmonella Saintpaul carrying one qnrS1 gene 
was reported in the Netherlands and Denmark [26, 27]. 
Salmonella Carno is a rare serotype, and this serovar has 
not been extensively studied.
To estimate genetic correlations, multi-locus 
sequence typing (MLST) was conducted. Nine isolates 
of ST19 type (seven Salmonella Typhimurium and two 
Salmonella 4,[5],12:i:-), 9 isolates of ST34 type (nine 
Salmonella 4,[5],12:i:-), 2 isolates of ST36 type (two 
Salmonella Typhimurium), ST27 type (two Salmonella 
Saintpaul), ST13 type (one Salmonella Agona and one 
Salmonella Hato) and ST469 type (two Salmonella 
Rissen) were identified. ST19 and ST34 were the pre-
dominant STs in Salmonella Typhimurium and Salmo-
nella 4,[5],12:i:-, which had high genetic diversity but 
were over 80% similar to each other (Fig. 1). ST19 and 
ST34 are more common in Salmonella Typhimurium 
STs responsible for infections worldwide [28, 29]. ST19 
and ST34 prevalence in Salmonella 4,[5],12:i:- has 
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significantly increased in Canada, and some of these 
STs demonstrate quinolone resistance [30]. It has been 
reported that ST19 is significantly associated with cip-
rofloxacin resistance in China [31] and that ST34 is 
linked to the nalidixic acid resistance in Africa [32]. 
Salmonella Agona ST13 was the most prevalent sero-
var isolated from chicken meat in Sri Lanka [33], and a 
Salmonella Agona strain isolated from chicken meat in 
China possessed a T57S substitution in ParC and car-
ried qnrS [34]. Salmonella Rissen ST469 was isolated 
from ready-to-eat mussels in Spain and pork products 
in Portugal [35, 36]. Moreover, ST469 was the third 
most predominant ST isolated from pork samples in 
China and nearly one-third of the ST469 isolates were 
resistant to ciprofloxacin [37]. However, the sequence 
type of one Salmonella Derby isolate could not be 
determined by MLST, suggesting the possibility that a 
potential novel ST of Salmonella Derby has emerged 
in South Korea.
Table 1 Isolation and antibiotic resistance information for Salmonella isolates evaluated in this study
ST sequence typing, QRDR quinolone-resistance determining region, PMQR plasmid-mediated quinolone resistance, MIC minimum inhibitory concentration
a Vitek II system with AST-N169 card
b E-test method
# Serotype Year ST ASTa. QRDR PMQR MICb.
Nalidixic acid Ciprofloxacin Levofloxacin 
29 Typhimurium 2016 19 R GyrA(D87Y) – 0.125 0.25
43 Typhimurium 2017 36 S – qnrS1 0.125 0.38
44 Typhimurium 2017 36 S – qnrS1 0.125 0.38
48 Typhimurium 2017 19 S – qnrS1 0.125 0.25
63 Typhimurium 2017 19 R GyrA(D87Y) – 0.125 0.25
53 Typhimurium 2018 19 R – qnrS1 0.19 0.38
17 Typhimurium 2018 16 R GyrA(S83F) – 0.125 0.25
19 Typhimurium 2018 19 R GyrA(D87Y) – 0.125 0.25
20 Typhimurium 2018 19 R – qnrS1 0.25 0.5
21 Typhimurium 2018 19 R GyrA(D87Y) qnrS1 0.25 0.75
13 I 4,[5],12:i:- 2017 34 R – qnrS1 0.19 0.38
22 I 4,[5],12:i:- 2018 34 S – qnrS1 0.125 0.25
23 I 4,[5],12:i:- 2018 34 R – qnrS1 0.19 0.38
24 I 4,[5],12:i:- 2018 19 S – qnrS1 0.125 0.38
25 I 4,[5],12:i:- 2018 34 S – qnrS1 0.125 0.25
54 I 4,[5],12:i:- 2018 34 R – qnrS1 0.19 0.5
55 I 4,[5],12:i:- 2018 34 R – qnrS1 0.19 0.38
57 I 4,[5],12:i:- 2018 34 R – qnrS1 0.125 0.38
59 I 4,[5],12:i:- 2018 34 R – qnrS1 0.19 0.5
50 I 4,[5],12:i:- 2018 19 R – qnrS1 0.25 0.5
61 I 4,[5],12:i:- 2019 34 R – qnrS1 0.25 1
11 Rissen 2017 469 R GyrA(S83Y), ParC(T57S) – 0.125 0.5
12 Rissen 2017 469 R GyrA(S83Y), ParC(T57S) – 0.125 0.38
2 Saintpaul 2017 27 R – qnrS1, aac(6’)-Ib-cr 0.5 0.38
3 Saintpaul 2017 27 R – qnrS1, aac(6’)-Ib-cr 0.5 0.38
8 Enteritidis 2017 11 R GyrA(D87N) – 0.032 0.25
10 Kentucky 2017 11 R GyrA(D87G) – 0.047 0.25
15 Carno 2017 1992 R ParC (T57S) qnrA, qnrB 0.19 0.5
16 Agona 2017 13 R ParC (T57S) qnrB 0.125 0.5
18 Hato 2018 13 R ParC (T57S) qnrS1 0.125 0.5
32 Duesseldorf 2016 292 R GyrA(S83F), ParC(T57S) – 0.125 0.25
51 Braenderup 2018 311 R ParC(T57S) qnrS2 0.19 0.5
52 Derby 2018 Undetermined S – qnrS1 0.125 0.38
62 Newport 2019 214 R – qnrS1 0.125 0.25
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Conclusions
We isolated 34 Salmonella strains with reduced suscep-
tibility to fluoroquinolones from human salmonellosis. 
Among them, Salmonella 4,[5],12:i:- and Salmonella 
Typhimurium were the most common serovars, and 
MLST revealed that ST19 and ST34 were the predomi-
nant lineages, with a high genetic similarity of over 80%. 
The spread of plasmid-mediated antibiotic resistance in 
ST19 and ST34 strains requires careful attention in South 
Korea. Furthermore, all isolates carried one or two of the 
PMQR genes, suggesting that various genes associated 
with quinolone resistance can be transferred horizontally 
among Enterobacteriaceae, causing human infections in 
South Korea.
Fig. 1 Phylogenetic tree based on MLST sequence typing of PMQR-positive Salmonella isolates from South Korea. The cluster analysis was 
performed using the categorical coefficient and the UPGMA in BioNumerics
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